Intervention
Adenosine
ClinicalTrials.gov intervention label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov intervention label, found in 6 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
6 shownNew MRI Methods Applied to Heart Failure With Preserved Ejection Fraction (HFpEF)NCT04600115 · 2017-03-03
RECRUITINGStress Test in Detecting Heart Damage in Premenopausal Women With Stage I-III Breast CancerNCT03505736 · 2018-06-21
COMPLETEDAdenosine and A2A Receptors in Human Brown Adipose TissueNCT03327168 · 2015-11-01
COMPLETEDStudy on Reflex Response During Temporary Stimulation and Inhibition of Chemoreceptors of Carotid Bodies - a Pilot StudyNCT01939912 · 2013-08-01
COMPLETEDEndothelial and Metabolic Effects of Glucagon-like Peptide-1 (GLP-1) in Coronary Circulation in Patients With Type 2 Diabetes MellitusNCT00923962 · 2009-06-01
COMPLETEDEffects of Body Mass Index on the Hyperemic Response to RegadenosonNCT00859833 · 2009-02-01
COMPLETEDCommon conditions
Obesity2Anatomic Stage I Breast Cancer AJCC v81Anatomic Stage IA Breast Cancer AJCC v81Anatomic Stage IB Breast Cancer AJCC v81Anatomic Stage II Breast Cancer AJCC v81Anatomic Stage IIA Breast Cancer AJCC v81Anatomic Stage IIB Breast Cancer AJCC v81Anatomic Stage III Breast Cancer AJCC v81Anatomic Stage IIIA Breast Cancer AJCC v81Anatomic Stage IIIB Breast Cancer AJCC v81Anatomic Stage IIIC Breast Cancer AJCC v81Decreased Vascular Flow1Endothelial Dysfunction1Heart Failure1MRI Scans1Peripheral Chemoreceptor Hypersensitivity1Premenopausal1Prognostic Stage I Breast Cancer AJCC v81Prognostic Stage IA Breast Cancer AJCC v81Prognostic Stage IB Breast Cancer AJCC v81Prognostic Stage II Breast Cancer AJCC v81Prognostic Stage IIA Breast Cancer AJCC v81Prognostic Stage IIB Breast Cancer AJCC v81Prognostic Stage III Breast Cancer AJCC v81Prognostic Stage IIIA Breast Cancer AJCC v81
Leading sponsors
Trial status mix
COMPLETED5
RECRUITING1
Phase mix
NA4
EARLY_PHASE11
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.